Identification of ADA as a Biomarker for Atypical Epstein Barr Virus Infection in Children
Klinische Pädiatrie · 01.07.2023 · 235 (04) · 221-227
DOI: 10.1055/a-2041-2986 ↗Kurz gefasst
Fachartikel in der Zeitschrift Klinische Pädiatrie, erschienen am 01.07.2023. Verfasst von Ting Shi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Soochow University Affiliated Children's Hospital, Suzhou, China. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Natural Science Foundation of Suzhou City.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objective
This study aims to explore the ability of adenosine deaminase (ADA) to discriminate atypical Epstein Barr virus (EBV) infection in children from acute febrile illness.
Methods
All children admitted to the Children’s Hospital of Soochow University between 2018 and 2019, who were acute febrile patients and subjected to the plasma EBV-DNA polymerase chain reaction (PCR) and indirect immunofluorescence (IIF) assay for EBV-specific antibodies assays. The diagnostic value of each detection index was compared by the area under the ROC curve.
Results
In children with atypical Epstein Barr virus infection, the sensitivity, specificity, positive predictive value, negative predictive value and Youden index were 62.87%, 100.00%,100.00%, 61.73% and 0.63 for EBV-DNA PCR assay, 80.84%, 100.00%, 100.00%, 75.76% and 0.81 for VCA-IgG avidity and 89.22%, 87.00%, 91.98%, 82.86% and 0.76 for ADA. VCA-IgG avidity (AUC=0.904, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Soochow University Affiliated Children's Hospital, Suzhou, China.
- Pediatric Intensive Care Unit, Soochow University Affiliated Children's Hospital, Suzhou, China.
Förderung
- Natural Science Foundation of Suzhou City
Zitieren
APA
Shi, T., Huang, L., Zhang, W., Shi, W., Wu, J., Bian, Y., Jiang, Y., & Tian, J. (2023). Identification of ADA as a Biomarker for Atypical Epstein Barr Virus Infection in Children. Klinische Pädiatrie, 235(04), 221-227. https://doi.org/10.1055/a-2041-2986
Vancouver
Shi T, Huang L, Zhang W, Shi W, Wu J, Bian Y, et al. Identification of ADA as a Biomarker for Atypical Epstein Barr Virus Infection in Children. Klinische Pädiatrie. 2023;235(04):221-227. doi:10.1055/a-2041-2986
BibTeX
@article{Shi2023,
author = {Shi, Ting and Huang, Linlin and Zhang, Wangsheng and Shi, Wenxin and Wu, Jiahui and Bian, Yuanxi and Jiang, Yanqun and Tian, Jianmei},
title = {Identification of ADA as a Biomarker for Atypical Epstein Barr Virus Infection in Children},
journal = {Klinische Pädiatrie},
year = {2023},
volume = {235},
number = {04},
pages = {221--227},
doi = {10.1055/a-2041-2986}
}
EUVIMED